MXRA8 and neoplasm: Furthermore, we probed insight into the tumor selectivity of the OVM and offered a rationale for defining the expression of MXRA8 and zinc-finger antiviral protein (ZAP) in tumors as a potential dual-biomarker for OV precision medicine in future clinical use.